全文获取类型
收费全文 | 5282篇 |
免费 | 293篇 |
国内免费 | 158篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 212篇 |
妇产科学 | 98篇 |
基础医学 | 863篇 |
口腔科学 | 48篇 |
临床医学 | 363篇 |
内科学 | 1289篇 |
皮肤病学 | 42篇 |
神经病学 | 525篇 |
特种医学 | 165篇 |
外科学 | 279篇 |
综合类 | 410篇 |
现状与发展 | 1篇 |
预防医学 | 601篇 |
眼科学 | 24篇 |
药学 | 571篇 |
中国医学 | 99篇 |
肿瘤学 | 121篇 |
出版年
2024年 | 8篇 |
2023年 | 88篇 |
2022年 | 128篇 |
2021年 | 195篇 |
2020年 | 238篇 |
2019年 | 163篇 |
2018年 | 187篇 |
2017年 | 169篇 |
2016年 | 158篇 |
2015年 | 167篇 |
2014年 | 386篇 |
2013年 | 451篇 |
2012年 | 229篇 |
2011年 | 323篇 |
2010年 | 239篇 |
2009年 | 302篇 |
2008年 | 257篇 |
2007年 | 285篇 |
2006年 | 191篇 |
2005年 | 221篇 |
2004年 | 124篇 |
2003年 | 133篇 |
2002年 | 99篇 |
2001年 | 103篇 |
2000年 | 65篇 |
1999年 | 70篇 |
1998年 | 71篇 |
1997年 | 72篇 |
1996年 | 41篇 |
1995年 | 55篇 |
1994年 | 56篇 |
1993年 | 43篇 |
1992年 | 49篇 |
1991年 | 45篇 |
1990年 | 36篇 |
1989年 | 34篇 |
1988年 | 21篇 |
1987年 | 16篇 |
1986年 | 27篇 |
1985年 | 27篇 |
1984年 | 26篇 |
1983年 | 25篇 |
1982年 | 18篇 |
1981年 | 24篇 |
1980年 | 16篇 |
1979年 | 11篇 |
1978年 | 9篇 |
1977年 | 6篇 |
1976年 | 7篇 |
1974年 | 7篇 |
排序方式: 共有5733条查询结果,搜索用时 468 毫秒
1.
目的 探讨郑州地区孕妇铁营养状况及其影响因素。方法 以2021年4—8月在郑州市某三家医院建立健康档案并进行孕期体检的孕妇作为研究对象进行问卷调查及铁营养状况检测,采用描述流行病学方法对孕妇铁营养状态进行分析,并采用单、多因素分析方法对孕妇铁缺乏状况影响因素进行分析。结果 共有3 258例孕妇参与本次研究,其中妊娠早期989例,占30.36%,妊娠中期1 125例,占34.53%,妊娠晚期1 144例,占35.11%。在3 258名孕妇中,共有773例为铁缺乏,铁缺乏的检出率为23.73%。多因素分析结果显示,年龄≥35岁(OR=2.726)、处于妊娠的中期或晚期(OR=3.037,3.438)、月经初潮年龄<13岁(OR=2.432)、经产妇(OR=3.493)、流产次数≥3次(OR=2.648)、孕前月经量≥100 mL/次(OR=2.420)、文化程度为初中及以上(OR=0.517,0.459)、居住在农村(OR=3.684)、家庭月收入>3 000元及以上(OR=0.601,0.542)、居住房屋装修时间<1年(OR=6.449)、罹患消化系统疾病(OR=4.716)、有营养补齐剂摄入(OR=0.355)是孕妇铁缺乏的影响因素。结论 郑州市孕妇铁缺乏检出率较高,需要尽早给予针对性的干预。部分因素被确定为该地区孕妇人群发生铁元素缺乏的影响因素,可选择性的对其中危险因素给予干预。 相似文献
2.
3.
目的以糖尿病心肌病大鼠为研究对象,探讨石斛合剂对糖尿病心肌病心肌细胞Ca^2+代谢的影响。方法 Wistar大鼠24只,取5只作为正常组,余19只采用高脂高糖饮食联合链脲佐菌素腹腔注射进行糖尿病心肌病造模。成模后,随机分为模型组、二甲双胍组、石斛合剂组。二甲双胍组、石斛合剂组分别予二甲双胍、石斛合剂灌胃,正常组、模型组予生理盐水灌胃。4周后,测空腹血糖,取左心室心肌组织进行组织病理学观察和心肌细胞内游离钙(MyoCa^2+)浓度测定,Western blot法检测肌浆网Ca^2+-ATP酶(SERCA2a)、L型钙通道α1C亚单位蛋白(CACNA1C)蛋白表达,RT-PCR法测定SERCA2a mRNA表达。结果石斛合剂组心肌纤维较模型组、二甲双胍组排列整齐,断裂较少。与正常组比较,模型组血糖、心肌细胞MyoCa^2+含量和CACNA1C蛋白表达明显升高(P<0.01,P<0.05),SERCA2a mRNA和蛋白表达明显降低(P<0.01)。与模型组比较,石斛合剂组血糖、心肌细胞MyoCa^2+含量和CACNA1C蛋白表达明显降低(P<0.01,P<0.05),SERCA2a mRNA和蛋白表达明显升高(P<0.01,P<0.05);二甲双胍组血糖明显降低(P<0.01)。与二甲双胍组比较,石斛合剂组心肌细胞MyoCa^2+含量明显降低(P<0.01,P<0.05),血糖、SERCA2a mRNA和蛋白表达明显升高(P<0.05)。结论石斛合剂通过提高SERCA2a mRNA和蛋白表达,加快摄取Ca^2+的速率,降低细胞质Ca^2+负荷,缓解钙超载,最终达到维持糖尿病心肌病钙稳态的作用,有效维持心肌细胞的正常收缩舒张功能;其降糖作用不是预防糖尿病心肌病的主要机理,而在于抑制CACNA1C蛋白表达,抑制钙诱导钙释放过程。 相似文献
4.
Sadanandavalli Retnaswami Chandra Pawan Raj Thomas Gregor Issac 《Indian journal of dermatology》2015,60(3):290-292
Neurodegeneration with brain iron accumulation (NBIA) is the term applied to a heterogeneous group of disorders resulting in iron deposition in the basal ganglia. Well-known phenotypic features are progressive regression with extra pyramidal involvement and a variable course. A 10-year-old child born to consanguineous parents presented with progressive generalized opisthotonic dystonia, retrocollis, oromandibular dyskinesias, apraxia for swallowing, optic atrophy and severe self-mutilation of lips. MR imaging showed brain iron accumulation. Other causes of self-mutilation were excluded. Early infantile onset, ophisthotonic dystonia with oromandibular dyskinesias and characteristic MR images are suggestive of NBIA. There is only one case reported in the literature of self-mutilation in this condition. 相似文献
5.
6.
Ramya Deepthi Vinnakota Allan S. Brett 《The American journal of the medical sciences》2019,357(2):160-163
Iron deficiency anemia is often listed among potential adverse effects of gastric acid-suppressive medications, given that gastric acidity promotes intestinal absorption of nonheme iron. Additionally, the antacid calcium carbonate can inhibit iron absorption. However, there is little direct clinical evidence that proton-pump inhibitors, histamine-2 receptor antagonists, or calcium carbonate cause iron deficiency anemia. Most case reports have had substantial limitations (e.g., minimal follow-up and presence of other causes of iron deficiency), and retrospective cohort studies have lacked sufficient patient-specific detail to make strong causal inferences. We present 2 cases—both with detailed, prospective 10-year follow-up—in which combinations of proton-pump inhibitors, histamine-2 receptor antagonists and calcium carbonate were clearly associated with development of iron deficiency anemia. Overt iron-deficiency anemia is probably uncommon in patients who use acid-modifying medications and who have no other conditions that predispose to iron deficiency. Nevertheless, clinicians should be aware of this potential complication, given widespread use of these agents. 相似文献
7.
Vahid MoazedElham JafariBita RashidiNezhadBehjat Kalantari-KhandaniAli NematiAhmad Naghibzadeh TahamiForoogh Mangeli 《Asian Pacific journal of cancer prevention》2020,21(1):239-241
Background: Myelodysplastic syndrome (MDS) is a heterogeneous hematological disease and certain serum factors are assumed to be involved in its pathogenesis and progression. Given this, our aim was to comparatively investigate the copper, zinc, and iron levels in MDS patients and healthy individuals. Methods: This case-control study was conducted on 31 patients with MDS (according to the WHO criteria after investigating laboratory tests such as peripheral blood smear and bone marrow aspiration) attending Bahonar Hospital, Kerman, Iran, and 31 healthy subjects from 2016 to 2018. The levels of copper, ceruloplasmin, zinc, ferritin, and iron were compared between the two groups. Results: Among the MDS patients, five individuals (16.13%) had low serum copper level (mean: 67.8 ± 4.35 µg/dl). Serum copper level was 111.3 ± 27.7 and 138.3 ± 26.6 in case and control groups, respectively (P = 0.0001). The serum zinc level and bone marrow iron level were also significantly different between the two groups (P < 0.05). Conclusion: Overall, it can be concluded that because only a small proportion of the MDS patients enrolled in this study were found to have lower copper levels compared with the MDS patients population, further studies with a larger sample size and also clinical trials in MDS patients with serum zinc, and copper deficiency are recommended, and post-treatment hematological reassessment would also be beneficial to achieving more definitive results. 相似文献
8.
9.
Moussa Ndong Machiko Kazami Tsukasa Suzuki Mariko Uehara Shin-ichi Katsumata Hirohumi Inoue Ken-Ichi Kobayashi Tadahiro Tadokoro Kazuharu Suzuki Yuji Yamamoto 《Nutrition Research》2009,29(9):640-647
Iron deficiency (ID) is one of the most commonly known forms of nutritional deficiencies. Low body iron is thought to induce neurologic defects but may also play a protective role against cancer development by cell growth arrest. Thus, ID may affect cellular pathways controlling cell growth and proliferation, the mechanism of which is still not fully understood. The serine/threonine protein kinase Akt and its downstream target, the mammalian Target of Rapamycin (mTOR), is known to play a crucial role in the regulation of cell growth and survival. Therefore, we hypothesized that Akt/mTOR pathway could be influenced by ID. Three-week-old male Wistar-strain rats were divided into 3 groups and the 2 groups had free access to a control diet (C group) or an iron-deficient diet (D group). The third group (PF group) were pair-fed the control diet to the mean intake of the D group. After 4 weeks, rats were killed and their brains were sampled. In separate experiments, COS-1 cells were cultured with or without the iron chelator deferoxamine. Western blots of brain samples and COS-1 lysates were used to analyze the expression and phosphorylation state of Akt, TSC2, mTOR, and S6 kinase proteins implicated in the Akt/mTOR pathway. Using 2 different ID models, we show for the first time that iron deficiency depresses Akt activity in rats and in COS-1 cells, leading to a decrease in mTOR activity. 相似文献
10.
铁缺乏时淋巴细胞增殖反应改变的实验研究 总被引:1,自引:0,他引:1
本研究采用体外细胞培养,3H-Tdr掺入,原子吸收光谱分析等技术方法,观察了低浓度Fe-cit时淋巴细胞内铁浓度变化及经ConA、PHA诱导的细胞增殖反应能力改变,结果显示:铁缺乏时(第2、3、4组)SI降低,与正常组(第1组)比较相差非常显著(P<0.01),SI与细胞内铁浓度的变化呈显著正相关(P<0.05,r1=0.9466,r2=0.9339),说明铁缺乏时淋巴细胞增殖反应能力受抑。 相似文献